Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT07535242
Serum GFAP, NfL, VEGF and Clinical Progression in Progressive MS
Sponsor: Ondokuz Mayıs University
View on ClinicalTrials.gov
Summary
This study aimed to investigate whether the biomarkers GFAP, NfL, and VEGF-recently considered important guides for better understanding the pathophysiology of MS-also serve as indicators of clinical progression in MS.
Official title: Investigation of the Relationship Between Serum GFAP, NfL, and VEGF Levels and Clinical Progression Markers in Progressive Multiple Sclerosis
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
OBSERVATIONAL
Enrollment
22
Start Date
2026-04-21
Completion Date
2026-05-05
Last Updated
2026-11-03
Healthy Volunteers
No
Conditions
Locations (1)
Ondokuz Mayis University
Samsun, Atakum, Turkey (Türkiye)